Researchers Awarded $10.5 Million to Explore AI's Role in Combating Cardiovascular Disease

Research teams from Kaiser Permanente Division of Research and the University of Michigan have been awarded a total of $10.5 million to explore the use of artificial intelligence (AI) in improving cardiovascular disease screening and treatment. Funded by the American Heart Association, these projects aim to leverage AI technology to enhance medical diagnostics and emergency care, addressing the leading cause of death in the U.S.

The Kaiser Permanente team, led by David Ouyang, M.D., will focus on using AI to expand the diagnostic capabilities of echocardiograms, potentially detecting early signs of kidney and liver disease during heart scans. This approach could lead to earlier treatment and reduced complications for patients with cardiovascular disease. Meanwhile, the University of Michigan team, under Cindy Hsu, M.D., Ph.D., M.S., is developing an AI-driven algorithm and wearable sensor to personalize CPR techniques during cardiac arrest, aiming to improve survival rates by ensuring more effective blood circulation.

These initiatives highlight the American Heart Association's commitment to advancing medical research through innovative technologies. With cardiovascular disease posing a significant global health challenge, the integration of AI into healthcare practices offers promising avenues for improving patient outcomes and saving lives.